Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 14, 2017; 23(14): 2519-2526
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2519
Variables | Univariate | Multivariable | ||||
Odds ratio | 95%CI | P value | Odds ratio | 95%CI | P value | |
Age (≥ 65 yr) | 1.26 | 0.73-2.23 | 0.410 | |||
Gender (male) | 4.22 | 1.88-11.3 | < 0.001 | 4.17 | 1.78-11.5 | < 0.001 |
Preoperative symptoms | 0.95 | 0.55-1.64 | 0.864 | |||
Diabetes mellitus | 1.14 | 0.49-2.45 | 0.755 | |||
Cardiac comorbidities | 1.81 | 1.02-3.18 | 0.041 | 1.55 | 0.83-2.87 | 0.166 |
Pulmonary comorbidities | 1.26 | 0.40-3.40 | 0.669 | |||
Body mass index (≥ 22) | 1.62 | 0.94-2.81 | 0.084 | |||
Preoperative PLR (< 0.71) | 2.94 | 1.66-5.35 | < 0.001 | 3.32 | 1.82-6.25 | < 0.001 |
Tumor location (lower third) | 0.62 | 0.34-1.11 | 0.107 | |||
Macroscopic tumor size (> 50 mm) | 1.19 | 0.69-2.05 | 0.534 | |||
UICC cT (cT4) | 1.30 | 0.67-2.69 | 0.457 | |||
UICC cN (cN1-3) | 1.75 | 1.01-3.08 | 0.045 | 1.69 | 0.93-3.08 | 0.083 |
Operative procedure (total gastrectomy) | 2.42 | 1.39-4.23 | 0.002 | 2.43 | 1.35-4.43 | < 0.001 |
- Citation: Inaoka K, Kanda M, Uda H, Tanaka Y, Tanaka C, Kobayashi D, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer. World J Gastroenterol 2017; 23(14): 2519-2526
- URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2519.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2519